Injectable Ketamine Shows Promise in Treatment-Resistant Depression
Twice-weekly subcutaneous ketamine helped alleviate symptoms of treatment-resistant depression, according to the phase III KADS study. Among those who received at least one flexible treatment dose (0.5-0.9 mg/kg), ketamine was more than 12-times better at inducing remission of depression than the benzodiazepine midazolam (remission rate 19.6% vs 2.0%, OR 12.1, 95% CI 2.1-69.2, P=0.005), reported […]
More Workers, Better Data Needed, Frontline Health Workers Tell House Members
WASHINGTON — More doctors and nurses on staff and in the pipeline are needed to help alleviate workforce shortages that have existed in healthcare for years and got much worse during the COVID-19 pandemic, witnesses said at a House hearing Wednesday. “Only a few weeks ago, a nurse in charge of my emergency department told […]